Ending Mail-Order Abortion Would Fulfill 3 Trump Campaign Promises
RYAN T. ANDERSON AND JAMIE BRYAN HALL
DECEMBER 17, 2025
Allegations surfaced last week that FDA Commissioner Martin Makary instructed the FDA to slow-walk its study of the dangers of the chemical abortion pill in order to avoid the issue being in play during the midterm elections. If this is true, it is a mistake.
We conducted the largest-known study of the abortion pill, using real-world data, which we coauthored and published at the Ethics and Public Policy Center. It found the abortion pill has severe risks, as we are confident that the FDA will conclude. In response to our study, Secretary of Health and Human Services Robert F. Kennedy had promised the Senate that at the very least the label would need to be updated — and he directed Makary to have the FDA conduct its own study, the one he’s now accused of delaying.